# Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

> **NCT02307448** · NA · TERMINATED · sponsor: **ACR Biologics, LLC** · enrollment: 80 (actual)

## Conditions studied

- Foot Ulcer Chronic
- Skin Ulcer Venous Stasis Chronic
- Pressure Ulcer

## Interventions

- **PROCEDURE:** Platelet Rich Plasma
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT02307448
- **Lead sponsor:** ACR Biologics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** Lack of patient enrollment and lack of reimbursement
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307448, "Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02307448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*